Back to companies
Lineage Cell Therapeutics, Inc.
LCTXUSNYSEPharmaceuticals & HealthcareLineage Cell Therapeutics, Inc.
Revenue
$14.6mn
YoY +53.2%
Operating income
-$36.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API